ClinConnect ClinConnect Logo
Search / Trial NCT05022199

Use of SPY Fluorescent Angiography to Reduce Ureteroenteric Stricture Rate Following Urinary Diversion

Launched by UNIVERSITY OF VIRGINIA · Aug 23, 2021

Trial Information

Current as of November 09, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is testing whether using SPY fluorescent angiography (a dye and special camera that helps doctors see blood flow) during open urinary diversion can reduce a common problem called ureteroenteric stricture—narrowing where the ureter connects to the urinary diversion. The researchers compare patients who have this SPY imaging during surgery with past patients who had the same surgery without SPY. The main goal is to see if the rate of these strictures by about 1.5 years after surgery is lower, and they also track whether people need to be readmitted within 90 days, or develop hydronephrosis, kidney infection, or other kidney problems in that first 90 days. No results are reported yet.

Who can join: adults 18 and older who are planning an open urinary diversion (not robotic) and can give informed consent. Pregnant women are excluded. If eligible, you would have SPY imaging during your surgery as part of the procedure, and then follow standard post-surgery care. The study is at the University of Virginia and is not randomized; it compares current patients to historic controls. Enrollment is focused on about 50 participants in the SPY group, with results not yet available.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Undergoing open urinary diversion
  • Exclusion Criteria:
  • Inability to provide informed consent
  • Robotic-assisted urinary diversion
  • Pregnant Women

About University Of Virginia

The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.

Locations

Charlottesville, Virginia, United States

Charlottesville, Virginia, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials